Gram-Negative Bacterial Infection Market : Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Nektar Therapeutics
The emergence and proliferation of highly resistant gram-negative bacteria is a major concern given the limited number of antimicrobial agents that are currently available to combat these organisms.
View full press release